93 7325 (Trandolapril 1 mg)
Pill with imprint 93 7325 is Beige, Capsule-shape and has been identified as Trandolapril 1 mg. It is supplied by Teva Pharmaceuticals USA.
Trandolapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction; heart attack and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7325
Trandolapril
- Imprint:
- 93 7325
- Strength:
- 1 mg
- Color:
- Beige
- Size:
- 8.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- Inactive Ingredients:
- ferric oxide yellow
lactose anhydrous
povidone k30
corn starch
sodium stearyl fumarate
FD&C Blue No. 2
aluminum oxide
FD&C Red No. 40
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0837 | AvKare, Inc. |
More about trandolapril
- Trandolapril Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Other brands: Mavik
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
